Creative Planning’s Xtant Medical Holdings XTNT Stock Holding History

Creative Planning’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17	Closed	–	–	4937
2016 Q4	$0	Buy	+17	New	+$147	﹤0.01%	4874

Other funds holding XTNT

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

GCM

Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Creative Planning's XTNT Position: Q1 2017 in Review

Creative Planning sold out of Xtant Medical Holdings (XTNT) in Q1 2017, closing a stake of 17 shares.

Creative Planning first reported a position in XTNT in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 18 funds tracked by Wall St. Rank hold XTNT as of Q1 2017.

Creative Planning reported no remaining Xtant Medical Holdings position as of Q1 2017 after selling out during the quarter.
Creative Planning sold 17 Xtant Medical Holdings shares in Q1 2017.
Creative Planning first reported a position in Xtant Medical Holdings in Q4 2016 and held it in 1 quarter.
Creative Planning's Xtant Medical Holdings position peaked at $0 in Q4 2016.
18 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2017.

Based on Creative Planning's 13F filing for Q1 2017, filed 7 Apr 2017.